Predicting ongoing pregnancy following ovulation induction with recombinant FSH in women with polycystic ovary syndrome

Human Reproduction

Volumn 20, Issue 7, 2005, Pages 1827-1832

  van Wely, Madelon ^a   Bayram, Neriman ^a   van der Veen, Fulco ^a   Bossuyt, Patrick M M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Clomiphene citrate; Ovulation induction; PCOS; Pregnancy; rFSH

Indexed keywords

ANDROGEN; CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; FOLLITROPIN; GLUCOSE; INSULIN; LUTEINIZING HORMONE; PRASTERONE SULFATE; RECOMBINANT FOLLITROPIN;

ADULT; AMENORRHEA; ANDROGEN BLOOD LEVEL; AREA UNDER THE CURVE; ARTICLE; CLINICAL FEATURE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DRUG RESPONSE; ENDOCRINE FUNCTION; FEMALE; FEMALE INFERTILITY; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OLIGOMENORRHEA; OVARY CYCLE; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PREDICTION; PREGNANCY; PROBABILITY; SCREENING; STATISTICAL MODEL; TRANSVAGINAL ECHOGRAPHY;

EID: 21644458571     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/deh891     Document Type: Article

References (20)

1. Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S and Escobar-Morreale HF (2000) A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 85,2434-2438.
2. Bayram N, Van Wely M, Kaaijk EM, Bossuyt PM and Van der Veen F (2004) Using an electrocautery strategy or recombinant follicle stimulating hormone to induce ovulation in polycystic ovary syndrome: randomised controlled trial. Br Med J 328,192-195.
3. Christin-Maitre S and Hugues JN (2003) A comparative randomized multicentric study comparing the step-up versus step-down protocol in polycystic ovary syndrome. Hum Reprod 18,1626-1631.
4. Diamanti-Kandaralis E, Kouli CR, Bergiele AT, Filandra FA, Tsiannateli TC and Spina GG (1999) A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 84,4006-4011.
5. Dutch Health Council guideline. http://www.cvz.nl/resources/rSBA97-007_tcm13-2650.pdf
6. Farquhar C, Vandekerckhove P and Lilford R (2004) Laparoscopic 'drilling' by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome (Cochrane Review). In The Cochrane Library, Issue 1. John Wiley & Sons, Chichester, UK.
7. Gore-Langton RE and Armstrong DT (1988) Follicular steroidogeneis and its control. In Knobil E and Neill J (eds) The Physiology of Reproduction. Raven Press, New York, pp. 331-385.
8. Hu Y, Cortvrindt R and Smitz J (2002) Effects of aromatase inhibition on in vitro follicle and oocyte development analyzed by early preantral mouse follicle culture. Moll Reprod Dev 61,549-559.
9. Hull MG (1987) Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies. Gynecol Endocrinol 1, 235-245.
10. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR and Azziz (1998) Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 83,3078-3082.
11. Mantzoros CS, Cramer DW, Liberman RF and Barbieri RL (2000) Predictive value of serum and follicular fluid leptin concentrations during assisted reproductive cycles in normal women and in women with the polycystic ovarian syndrome. Hum Reprod 15,539-544.
12. Mol BW, Van Wely M and Steyerberg EW (2000) Using prognostic models in clinical infertility. Hum Fertil 3,199-202.
13. Mulders AGM, Eijkemans MJ, Imani B and Fauser BC (2003) Prediction of chances for success or complications in gonadotrophin ovulation induction outcome in normogonadotrophic anovulatory indertility. Reprod Biomed Online 7,170-178.
14. National Institute of Clinical Excellence (NICE) of the British National Health Service. http://www.nice.org.uk/pdf/CG011niceguideline.pdf. Guideline 1.6.3-1.
15. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagniostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19,1-7.
16. Spritzer PM, Poy M, Wiltgen D, Mylius LS and Capp E (2001) Leptin concentrations in hirsute women with polycystic ovary syndrome or idiopathic hirsutism: influence on LH and relationship with hormonal, metabolic, and anthropometric measurements. Hum Reprod 16,1340-1346.
17. Steyerberg EW, Eijkemans MJ and Habbema JD (1999) Stepwise selection in small data sets: a simulation study of bias in logistic regression analysis. J Clin Epidemiol 52,935-942.
18. Teissier MP, Chable H, Paulhac S and Aubard Y (1999) Recombinant human follicle stimulating hormone versus human menopausal gonadotrophin induction: effects in mature follicle endocrinology. Hum Reprod 14,2236-2241.
19. Van Wely M, Bayram N and Van der Veen F (2003) Recombinant FSH in alternative doses or versus urinary gonadotrophins for ovulation induction in subfertility associated with polycystic ovary syndrome: a systematic review based on a Cochrane review. Hum Reprod 18, 1143-1149.
20. White DM, Polson DW, Kiddy D, Sagle P, Watson H. Gilling-Smith C, Hamilton-Fairley D and Franks S (1996) Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women. J Clin Endocrinol Metab 81,3821-3824.